Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy
- PMID: 36627643
- PMCID: PMC9830686
- DOI: 10.1186/s13073-022-01145-4
Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy
Abstract
Background: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, and histopathologic glomerular lesions are among the earliest structural alterations of DN. However, the signaling pathways that initiate these glomerular alterations are incompletely understood.
Methods: To delineate the cellular and molecular basis for DN initiation, we performed single-cell and bulk RNA sequencing of renal cells from type 2 diabetes mice (BTBR ob/ob) at the early stage of DN.
Results: Analysis of differentially expressed genes revealed glucose-independent responses in glomerular cell types. The gene regulatory network upstream of glomerular cell programs suggested the activation of mechanosensitive transcriptional pathway MRTF-SRF predominantly taking place in mesangial cells. Importantly, activation of MRTF-SRF transcriptional pathway was also identified in DN glomeruli in independent patient cohort datasets. Furthermore, ex vivo kidney perfusion suggested that the regulation of MRTF-SRF is a common mechanism in response to glomerular hyperfiltration.
Conclusions: Overall, our study presents a comprehensive single-cell transcriptomic landscape of early DN, highlighting mechanosensitive signaling pathways as novel targets of diabetic glomerulopathy.
© 2023. The Author(s).
Conflict of interest statement
DD is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. T.B. Huber reports having consultancy agreements with AstraZeneca, Bayer, Boehringer-Ingelheim, DaVita, Fresenius Medical Care, Novartis, and Retrophin; receiving research funding from Amicus Therapeutics, Fresenius Medical Care; and being on the editorial board of Kidney International and the advisory board of Nature Review Nephrology. The other authors declare that they have no competing interests.
Figures
Comment in
-
A central role for mesangial cells in the initiation of diabetic nephropathy.Kidney Int. 2023 Nov;104(5):872-874. doi: 10.1016/j.kint.2023.03.033. Kidney Int. 2023. PMID: 37863632 No abstract available.
References
-
- Stefansson VTN, Nair V, Melsom T, Looker HC, Mariani LH, Fermin D, Eichinger F, Menon R, Subramanian L, Ladd P, et al. Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease. Kidney Int. 2022;102(6):1345–1358. doi: 10.1016/j.kint.2022.07.033. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
